If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPartners Grp Regulatory News (PEYS)

Share Price Information for Partners Grp (PEYS)

Share Price is delayed by 15 minutes
Get Live Data
648.00    -2.00 (-0.31%)
Bid:
624.00
Ask:
644.00
Spread: 20.00 (3.205%)
Market Cap: £434.53m
PEYS Live PriceLast checked at - London Stock Exchange

Intraday Partners Grp Share Chart

Princess publishes Half-Year Report 2022

12 Aug 2022 13:45

RNS Number : 8985V
Princess Private Equity Holding Ltd
12 August 2022
 

News Release

 

 

Guernsey, 12 August 2022

 

 

Princess publishes Half-Year Report 2022

 

Princess Private Equity Holding Limited ("Princess" or the "Company") today published its Half-Year Report for 2022. The key items were:

 

· Net asset value ("NAV") decreased to EUR 13.76 per share, representing a total return of -7.5% including the first interim dividend.

· Share price total return over the same period was -13.5%.

· The first interim dividend of EUR 0.38 per share was paid to shareholders in June, in line with the objective to distribute 5% of opening NAV for each financial year, via semi-annual payments in June and December.

· Portfolio developments (-6.1%) were the main driver for the NAV decline during the first half of the year, while the impact of currency movements was positive (+0.4%). Among the largest positive contributors to performance during the reporting period were Princess' investments in AlliedUniversal and KinderCare.

· Princess received distributions amounting to EUR 100.9 million during the first six months of 2022. EUR 58.9 million stemmed from a partial redemption from its investment in senior loans. In line with previous guidance, the capital will be redeployed in direct private equity investments. An amount of EUR 38.2 million was received from direct investments, including proceeds from the sale of Voyage Care. The remaining EUR 3.8 million was received from the Company's mature legacy fund portfolio.

· Investment activity totalled EUR 62.7 million including new investments in Pharmathen, Forefront Dermatology, Precisely and Climeworks.

 

Richard Battey, Chairman comments: "Global capital market volatility dominated the first six months of 2022, with valuation developments being the main driver for the NAV decline. Despite the negative performance, Princess has compared favorably to public markets (e.g. MSCI World -13.5%) for a few key reasons. Firstly, the Company has a mature portfolio diversified across several vintage years, which tends to favor defensive assets in sectors with lower inherent cyclicality. Secondly, Princess' portfolio assets continued to have strong fundamental performance in H1. Thirdly, Partners Group's historically disciplined approach to investment underwriting and portfolio construction has helped prepare the portfolio for the increased volatility and macroeconomic uncertainty we currently see. Although economic challenges are unlikely to dissipate in the short term, I am confident that Princess is prepared to navigate the potentially uncertain times ahead."

 

A detailed analysis and commentary on the developments of Princess during H1 2022 is presented in the Half-Year Report published today, which can be accessed via: https://www.princess-privateequity.net/en/investor-relations/financial-reports/

A copy of the above document has been submitted to the National Storage Mechanism and will shortly be available for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism

Ends.

 

About Princess

Princess is an investment holding company founded in 1999 and domiciled in Guernsey. It invests, inter alia, in private equity and private debt investments. Princess is managed in its investment activities by Partners Group, a global private markets investment management firm with USD 131 billion in investment programs under management in private equity, private debt, private real estate and private infrastructure. Princess aims to provide shareholders with long-term capital growth and an attractive dividend yield. Princess is traded on the Main Market of the London Stock Exchange (ticker: PEY for the Euro Quote; PEYS for the Sterling Quote).

 

Contacts

Princess Private Equity Holding Limited:

princess@partnersgroup.com

www.princess-privateequity.net

 

Registered Number: 35241

 

LEI: 54930038LU8RDPFFVJ57

 

Investor relations contact

Phone: +44 207 575 2771

Email: princess@partnersgroup.com

 

Media relations contact

Jenny Blinch

Phone: +44 207 575 2571

Email: jenny.blinch@partnersgroup.com

www.partnersgroup.com

 

This document does not constitute an offer to sell or a solicitation of an offer to buy or subscribe for any securities and neither is it intended to be an investment advertisement or sales instrument of Princess. The distribution of this document may be restricted by law in certain jurisdictions. Persons into whose possession this document comes must inform themselves about and observe any such restrictions on the distribution of this document. In particular, this document and the information contained therein are not for distribution or publication, neither directly nor indirectly, in or into the United States of America, Canada, Australia or Japan.

 

This document may have been prepared using financial information contained in the books and records of the product described herein as of the reporting date. This information is believed to be accurate but has not been audited by any third party. This document may describe past performance, which may not be indicative of future results. No liability is accepted for any actions taken on the basis of the information provided in this document. Neither the contents of Princess' website nor the contents of any website accessible from hyperlinks on Princess' website (or any other website) is incorporated into, or forms part of, this announcement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRPTMBTMTIBBAT
Date   Source Headline
8th Jul 20267:00 amRNSPGPE Ltd publishes May NAV
6th Jul 20267:00 amRNSFree Cash Flow at 30 June 2026 and Buyback Update
2nd Jul 20267:00 amRNSTransaction in Own Shares
1st Jul 20267:00 amRNSTransaction in Own Shares
29th Jun 20267:00 amRNSTransaction in Own Shares
26th Jun 20267:00 amRNSTransaction in Own Shares
25th Jun 20267:00 amRNSTransaction in Own Shares
24th Jun 20267:00 amRNSTransaction in Own Shares
23rd Jun 20267:00 amRNSTransaction in Own Shares
18th Jun 20262:42 pmRNSResults of Annual General Meeting
18th Jun 20267:00 amRNSProposed Dual Share Class Structure
16th Jun 20267:00 amRNSTransaction in Own Shares
15th Jun 20267:00 amRNSTransaction in Own Shares
12th Jun 20267:00 amRNSPGPE Ltd publishes April NAV
12th Jun 20267:00 amRNSTransaction in Own Shares
11th Jun 20267:00 amRNSTransaction in Own Shares
10th Jun 20267:00 amRNSTransaction in Own Shares
9th Jun 20267:00 amRNSTransaction in Own Shares
27th May 20267:00 amRNSPGPE Ltd results presentation webcast details
18th May 20267:00 amRNSSave the date for Q1 2026 results announcement
7th May 20267:00 amRNSPGPE Ltd publishes March NAV
5th May 20267:00 amRNSDividend Declaration
1st May 20267:00 amRNSTransaction in Own Shares
30th Apr 20267:00 amRNSNotice of Annual General Meeting
14th Apr 20267:00 amRNSPGPE Ltd publishes February NAV
10th Apr 20267:00 amRNSTransaction in Own Shares
9th Apr 20267:00 amRNSTransaction in Own Shares
8th Apr 20267:00 amRNSBuyback update
7th Apr 20267:00 amRNSTransaction in Own Shares
31st Mar 20267:00 amRNSTransaction in Own Shares
30th Mar 20267:00 amRNSTransaction in Own Shares
23rd Mar 20267:00 amRNSAnnual results and webcast details
16th Mar 20267:00 amRNSPGPE Ltd publishes January NAV
16th Mar 20267:00 amRNSSave the date for 2025 annual results announcement
16th Mar 20267:00 amRNSSave the date for 2025 annual results announcement
16th Mar 20267:00 amRNSPGPE Ltd publishes January NAV
25th Feb 20267:00 amRNSTransaction in Own Shares
16th Feb 20267:00 amRNSPGPE Ltd publishes December NAV
12th Feb 20264:51 pmRNSHolding(s) in Company
12th Feb 20267:00 amRNSTransaction in Own Shares
9th Feb 20267:00 amRNSTransaction in Own Shares
5th Feb 20267:00 amRNSTransaction in Own Shares
30th Jan 20267:00 amRNSTransaction in Own Shares
29th Jan 20267:00 amRNSTransaction in Own Shares
28th Jan 20267:01 amRNSBuyback update
28th Jan 20267:00 amRNSTransaction in Own Shares
21st Jan 20267:00 amRNSTransaction in Own Shares
15th Jan 20267:00 amRNSTransaction in Own Shares
14th Jan 20267:00 amRNSFree Cash Flow as at 31 December 2025
8th Jan 20267:04 amRNSPGPE Ltd publishes November NAV

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.